The growth of Viagra and its effect on the medicinal landscape presents a complicated question for shareholders. While the first sales figures were astounding, the exclusivity has lapsed, leading to a flood of copycat https://tasneemfjgv799169.azzablog.com/41820399/the-blue-pill-and-big-pharma-a-dangerous-investment